Research Papers:

ILKAP, ILK and PINCH1 control cell survival of p53-wildtype glioblastoma cells after irradiation

Christina Hausmann _, Achim Temme, Nils Cordes and Iris Eke

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2015; 6:34592-34605. https://doi.org/10.18632/oncotarget.5423

Metrics: PDF 2189 views  |   HTML 2686 views  |   ?  


Christina Hausmann1, Achim Temme2, Nils Cordes1,3,4,5,6, Iris Eke1,7

1OncoRay – National Center for Radiation Research in Oncology, Medical Faculty Carl Gustav Carus, Technische Universität Dresden, 01307 Dresden, Germany

2Section of Experimental Neurosurgery/Tumor Immunology, Department of Neurosurgery University Hospital Carl Gustav Carus, Technische Universität Dresden, 01307 Dresden, Germany

3Department of Radiation Oncology, University Hospital and Medical Faculty Carl Gustav Carus, Technische Universität Dresden, 01307 Dresden, Germany

4Helmholtz-Zentrum Dresden – Rossendorf, Institute of Radiooncology, 01328 Dresden, Germany

5German Cancer Consortium (DKTK), 01307 Dresden, Germany

6German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany

7Radiation Oncology Branch, Center for Cancer Research, National Institutes of Health/National Cancer Institute, Bethesda, MD 20892, USA

Correspondence to:

Nils Cordes, e-mail: [email protected]

Iris Eke, e-mail: [email protected]

Keywords: ILKAP, DNA repair, radioresistance, ILK, PINCH1

Received: June 09, 2015     Accepted: September 25, 2015     Published: October 07, 2015


The prognosis is generally poor for patients suffering from glioblastoma multiforme (GBM) due to radiation and drug resistance. Prosurvival signaling originating from focal adhesion hubs essentially contributes to therapy resistance and tumor aggressiveness. As the underlying molecular mechanisms remain largely elusive, we addressed whether targeting of the focal adhesion proteins particularly interesting new cysteine-histidine-rich 1 (PINCH1), integrin-linked kinase (ILK) and ILK associated phosphatase (ILKAP) modulates GBM cell radioresistance. Intriguingly, PINCH1, ILK and ILKAP depletion sensitized p53-wildtype, but not p53-mutant, GBM cells to radiotherapy. Concomitantly, these cells showed inactivated Glycogen synthase kinase-3β (GSK3β) and reduced proliferation. For PINCH1 and ILKAP knockdown, elevated levels of radiation-induced γH2AX/53BP1-positive foci, as a marker for DNA double strand breaks, were observed. Mechanistically, we identified radiation-induced phosphorylation of DNA protein kinase (DNAPK), an important DNA repair protein, to be dependent on ILKAP. This interaction was fundamental to radiation survival of p53-wildtype GBM cells. Conclusively, our data suggest an essential role of PINCH1, ILK and ILKAP for the radioresistance of p53-wildtype GBM cells and provide evidence for DNAPK functioning as a central mediator of ILKAP signaling. Strategies for targeting focal adhesion proteins in combination with radiotherapy might be a promising approach for patients with GBM.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 5423